TAMPA, Fla.--(BUSINESS WIRE)-- Neutra Corp. (OTCBB: NTRR) announced today that the company is moving forward with plans to deliver innovative new addiction treatments to a hungry marketplace by shortlisting promising targets in the medical technology space.

“Traditional rehabilitation and treatment alone simply aren’t getting the results that people demand in the battle against addiction,” said NTRR CEO Michael-Shane Henderson. “Medical researchers have responded to this demand, and we could be on the cusp of new game-changing technologies that will soon allow NTRR to offer a more complete approach to addiction recovery.”